Rare diseases
Investigational molecules
Locations
382 conditions with trials, the busiest first
846 trials across Europe, recruiting first
Phase 2 Randomized Trial of Oral NS-863 in Patients with Pulmonary Arterial Hypertension
BelgiumLong‑Term Safety and Tolerability of Oral Iptacopan in Pediatric Patients with Paroxysmal Nocturnal Hemoglobinuria or IgA Nephropathy
ItalySafety and Efficacy of Extended‑Release Tacrolimus (VI‑0106) in Adults with Pulmonary Arterial Hypertension and Functional Limitations
CzechiaEffect of semaglutide on weight loss and metabolic control in liver transplant candidates with obesity
SpainEfficacy of upadacitinib plus short prednisolone tapering in adults with Giant Cell Arteritis
GermanySafety Study of DIAG723 and Sodium Chloride in Adults with Hereditary Hemorrhagic Telangiectasia
GermanyA Phase 3 Study of Once‑Daily Treprostinil Palmitil Inhalation Powder for Adults with Pulmonary Arterial Hypertension
AustriaSafety and dose‑finding study of CD19‑CART01 in patients with SLE, SSc, DM/PM, IMNM, AAV, MG, NMOSD, or chronic GVHD
ItalyEnhanced dual antiplatelet therapy with clopidogrel and acetylsalicylic acid for secondary prevention in patients with mild ischemic stroke
GermanyContinuing vs Stopping Acetylsalicylic Acid in Elderly Patients with Chronic Coronary Syndrome (Secondary Prevention): A Randomized Trial
NorwayIntravenous Sodium Thiosulfate Reduces Vascular Calcification in Hemodialysis Patients
The NetherlandsEffect of dapagliflozin on cardiovascular events in patients receiving chronic dialysis
SwedenThe therapies tested most often in Vascular disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
